mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for GATM
Gene summary
Basic gene Info.Gene symbolGATM
Gene nameglycine amidinotransferase (L-arginine:glycine amidinotransferase)
SynonymsAGAT|AT|CCDS3
CytomapUCSC genome browser: 15q21.1
Type of geneprotein-coding
RefGenesNM_001482.2,
Descriptionglycine amidinotransferase, mitochondrialtransamidinase
Modification date20141219
dbXrefs MIM : 602360
HGNC : HGNC
Ensembl : ENSG00000171766
HPRD : 03838
Vega : OTTHUMG00000131427
ProteinUniProt: P50440
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_GATM
BioGPS: 2628
PathwayNCI Pathway Interaction Database: GATM
KEGG: GATM
REACTOME: GATM
Pathway Commons: GATM
ContextiHOP: GATM
ligand binding site mutation search in PubMed: GATM
UCL Cancer Institute: GATM
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006601creatine biosynthetic process9218780


Top
Ligand binding site mutations for GATM
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
G402G402EBLCA1
G402G403RCOAD1
N300D298GGBM1
C407H406RKIRC1
N300D298YUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for GATM
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
N300D298G-1.032336
G402G402E-0.68685454
N300D298Y-0.54006622
G402G403R-0.39848268
C407H406R-0.31059057
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for GATM from PDB

Top
Differential gene expression and gene-gene network for GATM
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of GATM and the right PPI network was created from samples without mutations in the LBS of GATM. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for GATM
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C2675179Arginine:Glycine Amidinotransferase Deficiency3Biomarker, GeneticVariation
umls:C0018801Heart Failure1Biomarker
umls:C0007097Carcinoma1Biomarker
umls:C0022658Kidney Diseases1Biomarker
umls:C0024667Mammary Neoplasms, Animal1Biomarker
umls:C0024668Mammary Neoplasms, Experimental1Biomarker
umls:C0151744Myocardial Ischemia1Biomarker
umls:C0027540Necrosis1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for GATM
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|nutraceuticalDB00129L-OrnithineSmall molecule
Approved|nutraceutical|vet_approvedDB00145GlycineSmall molecule
ExperimentalDB02068Delta-Amino Valeric AcidSmall molecule
ExperimentalDB02530Gamma(Amino)-Butyric AcidSmall molecule
ExperimentalDB04185NorvalineSmall molecule
ExperimentalDB04454Alpha-Aminobutyric AcidSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of GATM go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NVA2-AMINOPENTANOIC ACID1jdxAC407
ARGARGININE4jdwAG402
ORNL-ORNITHINE3jdwAG402 C407
GLYGLYCINE RESIDUE5jdwAN300 G402 C407
ABUGAMMA-AMINOBUTYRIC ACID6jdwAN300 G402 C407
DAVDELTA-AMINO VALERIC ACID7jdwAN300 G402 C407


Top
Conservation information for LBS of GATM
Multiple alignments for P50440 in multiple species
LBSAA sequence# speciesSpecies
A256PCFDAADFIRA6Homo sapiens, Danio rerio, Gallus gallus, Bos taurus, Mus musculus, Rattus norvegicus
A256PCFDAADFMRA1Xenopus tropicalis
A306PMHIDATFNII6Homo sapiens, Danio rerio, Xenopus tropicalis, Bos taurus, Mus musculus, Rattus norvegicus
A306PMHIDTTFNII1Gallus gallus
C407GGGFHCWTCDV4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
C407GGGFHCWTCDI2Xenopus tropicalis, Gallus gallus
C407GGGFHCWTTDV1Danio rerio
D170AAMPRDILLVV2Xenopus tropicalis, Gallus gallus
D170SAMPRDILMVV2Mus musculus, Rattus norvegicus
D170SAMPRDILIVV1Homo sapiens
D170AAMPRDILMVV1Danio rerio
D170GAMPRDILIVV1Bos taurus
D305NPMHIDATFNI6Homo sapiens, Danio rerio, Xenopus tropicalis, Bos taurus, Mus musculus, Rattus norvegicus
D305NPMHIDTTFNI1Gallus gallus
G402NANSLGGGFHC4Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus
G402HANSLGGGFHC3Danio rerio, Xenopus tropicalis, Gallus gallus
H303DPNPMHIDATF6Homo sapiens, Danio rerio, Xenopus tropicalis, Bos taurus, Mus musculus, Rattus norvegicus
H303DPNPMHIDTTF1Gallus gallus
L358MSSKWLSMNVL7Homo sapiens, Danio rerio, Xenopus tropicalis, Gallus gallus, Bos taurus, Mus musculus, Rattus norvegicus
M167GLYSAMPRDIL3Homo sapiens, Mus musculus, Rattus norvegicus
M167GMYAAMPRDIL3Danio rerio, Xenopus tropicalis, Gallus gallus
M167GLYGAMPRDIL1Bos taurus
M302KDPNPMHIDAT6Homo sapiens, Danio rerio, Xenopus tropicalis, Bos taurus, Mus musculus, Rattus norvegicus
M302KDPNPMHIDTT1Gallus gallus
N300SFKDPNPMHID7Homo sapiens, Danio rerio, Xenopus tropicalis, Gallus gallus, Bos taurus, Mus musculus, Rattus norvegicus
R169YAAMPRDILLV2Xenopus tropicalis, Gallus gallus
R169YSAMPRDILMV2Mus musculus, Rattus norvegicus
R169YSAMPRDILIV1Homo sapiens
R169YAAMPRDILMV1Danio rerio
R169YGAMPRDILIV1Bos taurus
R322LSNPDRPCHQI6Homo sapiens, Xenopus tropicalis, Gallus gallus, Bos taurus, Mus musculus, Rattus norvegicus
R322LSNPDRPCRQI1Danio rerio
S354HPLWMSSKWLS7Homo sapiens, Danio rerio, Xenopus tropicalis, Gallus gallus, Bos taurus, Mus musculus, Rattus norvegicus
S355PLWMSSKWLSM7Homo sapiens, Danio rerio, Xenopus tropicalis, Gallus gallus, Bos taurus, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas